Good clinical study information….!

Novartis will fund a $20 million research center at the University of Pennsylvania in a deal in which the drugmaker gains technology that uses manipulated immune-system cells to fight cancer. Copy and paste the below into your browser for more information or contact us at

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha Captcha Reload